James Robinson (biopharmacist) explained

James Robinson
Workplaces:	G.D. Searle, LLC Sanofi Pasteur Novavax Merck Coalition for Epidemic Preparedness Innovations (CEPI)

James (Jim) Robinson is the vice chair of the Coalition for Epidemic Preparedness Innovations (CEPI).

Robinson manages the CEPI manufacturing strategy for a COVID-19 vaccine.^[1]

Career

Robinson began his career as a biochemical engineer with G.D. Searle and worked at various companies before becoming the head of technical support for Merck's vaccine, biologics and sterile manufacturing in 2010.^{[2] [3]}

In 2017, Robinson began serving on CEPI's scientific advisory board. He was made vice-chair in 2019.

On February 16, 2022, Robinson was awarded a two-year, $340,000 grant by the Arnold Ventures Foundation to study biosimilars to determine potential cost savings from wider use of them.^[4]

References

1. Web site: 'Our moon shot': The world needs a coronavirus vaccine ASAP. Despite drugmakers billion-dollar bets, one might not be available for years.. Heath. Elizabeth Weise and David. 26 April 2020. USA TODAY. en-US. 2020-05-20.
2. A Crisis Gives You WIngs. Dumiak. Michael. 2017. Iavi Report: Newsletter on International Aids Vaccine Research. 21 . 1 . 4–9 . 29901872 . en-gb. 2020-05-20.
3. Web site: The Little-Known Coalition Tasked With Saving The World From COVID-19. Wright. Rob. 27 March 2020. Life Science Leader. 2020-05-20.
4. Web site: MacNeil . Matt . 2022-02-16 . James Robinson receives grant to study biosimilars . 2023-04-06 . UC Berkeley Public Health . en-US.